%0 Journal Article
%T Evaluation of Therapeutic Adherence in Patients Suffering from Chronic Inflammatory Rheumatism in the Rheumatology Wards of Lomé (Togo)
%A Eyram Fianyo
%A Wendlassida Jo£¿lle St¨¦phanie Zabsonre Tiendrebeogo
%A Viwal¨¦ Etonam Sika Koffi-Tessio
%A Kodjo Kakpovi
%A Owonayo Oniankitan
%A Moustafa Mijiyawa
%J Open Journal of Rheumatology and Autoimmune Diseases
%P 88-97
%@ 2164-005X
%D 2023
%I Scientific Research Publishing
%R 10.4236/ojra.2023.134009
%X <b><span style=\"font-family:Verdana;\">Objectives</span></b><span style=\"font-family:Verdana;\">: Therapeutic compliance can be defined as the degree of adequacy between
a patient¡¯s behaviour and his doctor¡¯s recommendations. Non-adherence</span><span style=\"font-family:&quot;\"><span style=\"font-family:Verdana;\"> to treatment has serious consequences in terms of morbidity and
mortality. Our aim was to assess adherence among patients treated for chronic
inflammatory rheumatism in Lom¨¦. </span><b><span style=\"font-family:Verdana;\">Patients and Methods</span></b><span style=\"font-family:Verdana;\">: This was a
multicentre cross-sectional study conducted from January 2015 to December 2021.
Patients aged 18 years or older, treated in the rheumatology departments of the
Sylvanus Olympio University Hospital or the B¨¨ Hospital during the study
period, were included if they were diagnosed with chronic inflammatory
rheumatism and started on disease-modifying therapy. Adherence was assessed
using the Compliance Questionnaire Rheumatology 19 questionnaire, with a
threshold for good compliance set at 80%. </span><b><span style=\"font-family:Verdana;\">Results</span></b><span style=\"font-family:Verdana;\">: Out of 13,214
patients received, 159 suffered from chronic inflammatory rheumatism (hospital
frequency 1.5%), and 60 met the inclusion criteria for our study. There were 55
women (91.7%) and 5 men (8.3%), giving a sex-ratio of 1/11. The mean age was
49.5 ¡À 13.5 years (extremes: 19 and 78 years). Rheumatoid arthritis (68.3%) was
the most common rheumatic disease, followed by undefined rheumatic diseases
(16.6%) and spondyloarthritis (8.3%). Average compliance with treatment was
76.9</span></span><span style=\"font-family:Verdana;\">%</span><span style=\"font-family:&quot;\"><span style=\"font-family:Verdana;\"> ¡À 12.4% (extremes 29.8 and 91.2). There was no statistically significant
difference according to the type of rheumatism. </span><b><span style=\"font-family:Verdana;\">Conclusion</span></b><span style=\"font-family:Verdana;\">: Overall
compliance was poor, with a Compliance Questionnaire Rheumatology 19 of less
than 80%. It was non-significantly influenced by socioeconomic status, disease
severity and duration of progression.</span></span>
%K Therapeutic Adherence
%K Non-Adherence
%K Chronic Inflammatory Rheumatism
%K Black Africa
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=129488